Enhanced collateral growth by double transplantation of gene-nucleofected fibroblasts in ischemic hindlimb of rats

PLoS ONE

Volumn 6, Issue 4, 2011, Pages

  Zhang, Ziyang ^a,b   Slobodianski, Alex ^b   Ito, Wulf D ^c   Arnold, Astrid ^b   Nehlsen, Jessica ^b   Weng, Shaoxiang ^d,e   Lund, Natalie ^e   Liu, Jihong ^f   Egaña, José Tomás ^a,g   Lohmeyer, Jörn A ^a   Müller, Daniel F ^a   Machens, Hans Günther ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF LÜBECK   (Germany)

^c UNIVERSITY OF ULM   (Germany)

^d ZHEJIANG UNIVERSITY   (China)

^e UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^f HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^g UNIVERSITY OF CHILE   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; VASCULOTROPIN 165; FIBROBLAST GROWTH FACTOR 2; VASCULOTROPIN A;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY LIGATION; ARTICLE; CELL BASED GENE THERAPY; CELL ISOLATION; CONTROLLED STUDY; EX VIVO STUDY; FEMORAL ARTERY; FIBROBLAST; FIBROBLAST CULTURE; GASTROCNEMIUS MUSCLE; GENETIC TRANSFECTION; HINDLIMB; IN VIVO STUDY; LIMB ISCHEMIA; MALE; MICRO-COMPUTED TOMOGRAPHY; MUSCLE PERFUSION; NONHUMAN; POLYMERASE CHAIN REACTION; QUANTITATIVE STUDY; RAT; SOLEUS MUSCLE; VASCULARIZATION; ANGIOGENESIS; ANIMAL; CELL CULTURE; COLLATERAL CIRCULATION; GENETICS; ISCHEMIA; METABOLISM; PATHOLOGY; PHYSIOLOGY; PLASMID; TRANSPLANTATION;

RATTUS;

ANIMALS; CELLS, CULTURED; COLLATERAL CIRCULATION; FIBROBLAST GROWTH FACTOR 2; FIBROBLASTS; HINDLIMB; ISCHEMIA; MALE; NEOVASCULARIZATION, PHYSIOLOGIC; PLASMIDS; RATS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 79955562266     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0019192     Document Type: Article

References (38)

1. Beard JD, (2000) Chronic lower limb ischemia. West J Med 173: 60-63.
2. Holzbach T, Vlaskou D, Neshkova I, Konerding MA, Wortler K, et al. (2010) Non-viral VEGF(165) gene therapy-magnetofection of acoustically active magnetic lipospheres ('magnetobubbles') increases tissue survival in an oversized skin flap model. J Cell Mol Med 14: 587-599.
3. Spanholtz T, Maichle A, Niedworok C, Stoeckelhuber BM, Kruger S, et al. (2009) Timing and targeting of cell-based VEGF165 gene expression in ischemic tissue. J Surg Res 151: 153-162.
4. Harder Y, Amon M, Laschke MW, Schramm R, Rucker M, et al. (2008) An old dream revitalised: preconditioning strategies to protect surgical flaps from critical ischaemia and ischaemia-reperfusion injury. J Plast Reconstr Aesthet Surg 61: 503-511.
5. Spanholtz TA, Theodorou P, Holzbach T, Wutzler S, Giunta RE, et al. (2010) Vascular Endothelial Growth Factor (VEGF(165)) Plus Basic Fibroblast Growth Factor (bFGF) Producing Cells induce a Mature and Stable Vascular Network-a Future Therapy for Ischemically Challenged Tissue. J Surg Res.
6. Baffour R, Berman J, Garb JL, Rhee SW, Kaufman J, et al. (1992) Enhanced angiogenesis and growth of collaterals by in vivo administration of recombinant basic fibroblast growth factor in a rabbit model of acute lower limb ischemia: dose-response effect of basic fibroblast growth factor. J Vasc Surg 16: 181-191.
7. Takeshita S, Isshiki T, Ochiai M, Eto K, Mori H, et al. (1998) Endothelium-dependent relaxation of collateral microvessels after intramuscular gene transfer of vascular endothelial growth factor in a rat model of hindlimb ischemia. Circulation 98: 1261-1263.
8. Lederman RJ, Mendelsohn FO, Anderson RD, Saucedo JF, Tenaglia AN, et al. (2002) Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study): a randomised trial. Lancet 359: 2053-2058.
9. Rajagopalan S, Mohler ER 3rd, Lederman RJ, Mendelsohn FO, Saucedo JF, et al. (2003) Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease: a phase II randomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermittent claudication. Circulation 108: 1933-1938.
10. Asahara T, Bauters C, Zheng LP, Takeshita S, Bunting S, et al. (1995) Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo. Circulation 92: II365-371.
11. George ML, Eccles SA, Tutton MG, Abulafi AM, Swift RI, (2000) Correlation of plasma and serum vascular endothelial growth factor levels with platelet count in colorectal cancer: clinical evidence of platelet scavenging? Clin Cancer Res 6: 3147-3152.
12. Lazarous DF, Shou M, Stiber JA, Dadhania DM, Thirumurti V, et al. (1997) Pharmacodynamics of basic fibroblast growth factor: route of administration determines myocardial and systemic distribution. Cardiovasc Res 36: 78-85.
13. Mullane EM, Dong Z, Sedgley CM, Hu JC, Botero TM, et al. (2008) Effects of VEGF and FGF2 on the revascularization of severed human dental pulps. J Dent Res 87: 1144-1148.
14. Yasuhara T, Shingo T, Muraoka K, wen Ji Y, Kameda M, et al. (2005) The differences between high and low-dose administration of VEGF to dopaminergic neurons of in vitro and in vivo Parkinson's disease model. Brain Res 1038: 1-10.
15. Harrigan MR, Ennis SR, Masada T, Keep RF, (2002) Intraventricular infusion of vascular endothelial growth factor promotes cerebral angiogenesis with minimal brain edema. Neurosurgery 50: 589-598.
16. Cuevas P, Carceller F, Ortega S, Zazo M, Nieto I, et al. (1991) Hypotensive activity of fibroblast growth factor. Science 254: 1208-1210.
17. Ferraro B, Cruz YL, Coppola D, Heller R, (2009) Intradermal delivery of plasmid VEGF(165) by electroporation promotes wound healing. Mol Ther 17: 651-657.
18. Nikol S, (2007) Viral or non-viral angiogenesis gene transfer-New answers to old questions. Cardiovasc Res 73: 443-445.
19. Bonadio J, Smiley E, Patil P, Goldstein S, (1999) Localized, direct plasmid gene delivery in vivo: prolonged therapy results in reproducible tissue regeneration. Nat Med 5: 753-759.
20. Kondoh K, Koyama H, Miyata T, Takato T, Hamada H, et al. (2004) Conduction performance of collateral vessels induced by vascular endothelial growth factor or basic fibroblast growth factor. Cardiovasc Res 61: 132-142.
21. Herzog S, Sager H, Khmelevski E, Deylig A, Ito WD, (2002) Collateral arteries grow from preexisting anastomoses in the rat hindlimb. Am J Physiol Heart Circ Physiol 283: H2012-2020.
22. Ito WD, Arras M, Scholz D, Winkler B, Htun P, et al. (1997) Angiogenesis but not collateral growth is associated with ischemia after femoral artery occlusion. Am J Physiol 273: H1255-1265.
23. Nikol S, (2008) Gene therapy of cardiovascular disease. Curr Opin Mol Ther 10: 479-492.
24. Khmelewski E, Becker A, Meinertz T, Ito WD, (2004) Tissue resident cells play a dominant role in arteriogenesis and concomitant macrophage accumulation. Circ Res 95: E56-64.
25. Choo PW, Rand CS, Inui TS, Lee ML, Ma CC, et al. (2000) A pharmacodynamic assessment of the impact of antihypertensive non-adherence on blood pressure control. Pharmacoepidemiol Drug Saf 9: 557-563.
26. Aluigi M, Fogli M, Curti A, Isidori A, Gruppioni E, et al. (2006) Nucleofection is an efficient nonviral transfection technique for human bone marrow-derived mesenchymal stem cells. Stem Cells 24: 454-461.
27. Cesnulevicius K, Timmer M, Wesemann M, Thomas T, Barkhausen T, et al. (2006) Nucleofection is the most efficient nonviral transfection method for neuronal stem cells derived from ventral mesencephali with no changes in cell composition or dopaminergic fate. Stem Cells 24: 2776-2791.
28. Jacobsen F, Mertens-Rill J, Beller J, Hirsch T, Daigeler A, et al. (2006) Nucleofection: a new method for cutaneous gene transfer? J Biomed Biotechnol 2006: 26060.
29. Zeitelhofer M, Vessey JP, Thomas S, Kiebler M, Dahm R, (2009) Transfection of cultured primary neurons via nucleofection. Curr Protoc Neurosci Chapter 4: Unit4 32.
30. Kang J, Ramu S, Lee S, Aguilar B, Ganesan SK, et al. (2009) Phosphate-buffered saline-based nucleofection of primary endothelial cells. Anal Biochem 386: 251-255.
31. Mueller CK, Thorwarth MW, Schultze-Mosgau S, (2010) Angiogenic gene-modified fibroblasts for induction of localized angiogenesis. J Surg Res 160: 340-348.
32. Doi K, Ikeda T, Marui A, Kushibiki T, Arai Y, et al. (2007) Enhanced angiogenesis by gelatin hydrogels incorporating basic fibroblast growth factor in rabbit model of hind limb ischemia. Heart Vessels 22: 104-108.
33. Fujita M, Ishihara M, Shimizu M, Obara K, Nakamura S, et al. (2007) Therapeutic angiogenesis induced by controlled release of fibroblast growth factor-2 from injectable chitosan/non-anticoagulant heparin hydrogel in a rat hindlimb ischemia model. Wound Repair Regen 15: 58-65.
34. Marui A, Tabata Y, Kojima S, Yamamoto M, Tambara K, et al. (2007) A novel approach to therapeutic angiogenesis for patients with critical limb ischemia by sustained release of basic fibroblast growth factor using biodegradable gelatin hydrogel: an initial report of the phase I-IIa study. Circ J 71: 1181-1186.
35. Olea FD, Vera Janavel G, Cuniberti L, Yannarelli G, Cabeza Meckert P, et al. (2009) Repeated, but not single, VEGF gene transfer affords protection against ischemic muscle lesions in rabbits with hindlimb ischemia. Gene Ther 16: 716-723.
36. Gravier R, Dory D, Laurentie M, Bougeard S, Cariolet R, et al. (2007) In vivo tissue distribution and kinetics of a pseudorabies virus plasmid DNA vaccine after intramuscular injection in swine. Vaccine 25: 6930-6938.
37. Parker SE, Monteith D, Horton H, Hof R, Hernandez P, et al. (2001) Safety of a GM-CSF adjuvant-plasmid DNA malaria vaccine. Gene Ther 8: 1011-1023.
38. Bembenek A, Lotterer E, Machens A, Cario H, Krause U, et al. (1998) Neuroendocrine tumor of the common hepatic duct: a rare cause of extrahepatic jaundice in adolescence. Surgery 123: 712-715.